Robert J. Weiland
Keine laufenden Positionen mehr
Karriereverlauf von Robert J. Weiland
Ehemalige bekannte Positionen von Robert J. Weiland
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2016 | 24.01.2020 |
| Independent Dir/Board Member | 01.04.2016 | 24.01.2020 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.2009 | 01.01.2016 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01.12.2005 | 01.05.2008 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01.01.2004 | 01.01.2006 |
| PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | 01.04.2016 | - |
Ausbildung von Robert J. Weiland
| DeSales University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
- Börse
- Insiders
- Robert J. Weiland
- Erfahrung
